Focus On Cancer

Focus On Cancer

By Cancer Treatment Centers of America (CTCA)ScienceMedicineHealth & FitnessEducation
Download on the App Store

Focus On Cancer episodes

  • S2E8 | Advances in medicine: Progress, and the promise

    Gene-editing tools that make the body smarter in fighting cancer. Robots that help surgeons more precisely excise a tumor. Screening technologies that can spot lung tumors the size of a grain of rice. This gee-whiz age of innovation and technological genius looks a lot different than the horse-and-buggy era of the early 1900s when today’s everyday essentials like anesthesia and antiseptic surgeries were only beginning to catch on. And there are even more groundbreaking opportunities on the horizon. On today’s episode of Focus on Cancer, our host, Pat Basu, MD, MBA, President & CEO of Cancer Treatment Centers of America® (CTCA), welcomes entrepreneur and technology-sector leader John Bardis to map out the progress, and the promise, of technological advances—yesterday, today and tomorrow.

    35 min
  • S2E7 | It’s time to end disparities in cancer care. Here’s how.

    Important progress is being made in the fight against cancer—namely, cancer incidence and death rates continue to fall across the United States. But some minority groups are immune to those advances, negatively impacted by a cancer-disparities trend that disproportionately impacts certain racial, ethnic and socioeconomic demographics—none more than the African-American community. In this episode of Focus on Cancer, our host, Pat Basu, MD, MBA, President & CEO of Cancer Treatment Centers of America® (CTCA), welcomes Anita Johnson, MD, Breast Cancer Program Director at CTCA®, for a robust conversation around the impact of cancer disparities, and what we can do to address them.

    30 min
  • S2E6 | Integrative care: Treating the whole cancer patient—mind, body & spirit

    When you’ve been diagnosed with cancer, you quickly learn that fighting the disease itself is only half the battle. There are also other impacts on your life—from side effects like pain and nausea to changes in your relationships to learning to manage long-term effects as a survivor after treatment. That’s why it’s important to have an integrative care plan that incorporates side-effect management, social support, and survivorship into your cancer treatment regimen. On this episode of Focus on Cancer, our host, Pat Basu, MD, MBA, President & CEO of Cancer Treatment Centers of America® (CTCA), welcomes Carolyn Lammersfeld, Vice President of Integrative Care Services at CTCA®, for a robust discussion on integrative care and its important role in the cancer journey.

    33 min
  • S2E5 | Your DNA and the Cancer Clues That May Be Hiding There

    It’s been nearly 70 years since Cambridge University scientists James D. Watson and Francis H.C. Crick discovered the double-helix structure of DNA. In the decades since, our evolving understanding of the human genome has had a profound impact on treatment advances for diseases like cancer. To commemorate Watson and Crick’s groundbreaking discovery, and the mapping of the full human genome 50 years later, DNA Day was designated as a time of public reflection and education around genetics and genomics. To celebrate the occasion, our host, Pat Basu, MD, MBA, President & CEO of Cancer Treatment Centers of America® (CTCA), and his guest, CTCA® Genetic Counselor Eric Fowler, discuss the role genetic testing and counseling play in the cancer journey.

    40 min
  • S2E4 | Keeping the faith: Spiritual support’s role in the cancer journey

    With a cancer diagnosis comes many worries and questions—what will treatment be like? How do I tell my friends and family? For many cancer patients, the diagnosis also comes with existential questions about life, the world around them and their place in it. Some find solace, meaning and purpose through the guidance of a spiritual support program—an increasingly important part of the integrative care model for patients of faith. What exactly is spiritual support, and what role does it play in the cancer journey? On this episode of Focus on Cancer, our host, Pat Basu, MD, MBA, President & CEO of Cancer Treatment Centers of America® (CTCA), sits down with Rev. Percy McCray Jr., Director of Faith-Based Programs at CTCA®, to answer these and other questions.

    42 min
  • S2E3 | Managing cancer risk: Screening and prevention

    For Marnee Spierer, MD, fighting breast cancer is more than a job. It’s also a family legacy that’s impacted at least three generations of the women in her family. So, when her sister became the latest to be diagnosed with the disease, Dr. Spierer—Radiation Oncologist and Chief of Staff and Chief of Radiation Oncology at Cancer Treatment Centers of America® (CTCA), Phoenix—was faced with some very personal decisions. In today’s episode of Focus on Cancer, Dr. Spierer joins our host, Pat Basu, MD, MBA, President and CEO of CTCA®, to talk about her experience with genetic testing and counseling, what led her to decide to undergo a prophylactic mastectomy and learning firsthand—as an oncologist and a woman—about the importance of managing your risk of cancer.

    32 min
  • S2E2 | Vaccines, for COVID and cancer: What patients need to know
    Nearly a year into the worst public health crisis in 100 years, there’s hope, and true progress, on the horizon. Two promising COVID-19 vaccines are being distributed around the country, and millions of Americans have rolled up their sleeves to be inoculated against the deadly virus. But amid the optimism is some skepticism, and a ton of questions—especially among cancer patients: How will the vaccine affect me? Is it safe? Should I even get it? In today’s episode, Mashiul Chowdhury, MD, Infectious Disease Program Director at Cancer Treatment Centers of America® (CTCA), joins our host, CTCA® President & CEO Pat Basu, MD, MBA, to answer those questions, and more.
    33 min
  • S2E1 | Expanding value-based care, clinical trials, mental health support: 
A conversation with Dr. Atul Dhir
    Like many men and women who’ve had their lives upended by a cancer diagnosis, Atul Dhir found his journey with lymphoma to be deeply transformative, inspiring the arc of a career that has allowed him to help patients on many fronts—as a physician, a scientist and an innovator in the delivery of care and the development of anti-cancer drug therapies. A survivor of stage IV Hodgkin lymphoma (which later morphed into large-cell non-Hodgkin lymphoma), Dr. Dhir sits down with the host of Focus on Cancer, Cancer Treatment Centers of America® (CTCA) President & CEO Pat Basu, to share an insider’s look inside some innovations with the power to revolutionize the patient experience.
    37 min
  • S1E12 | Traveling for treatment, whole-person care & ‘out-of-the-box’ thinking: A conversation with rare cancer patient Eric K.
    At the age of 43, married with three children and at the pinnacle of his career as the police chief of a small Texas suburb, Eric K. says he was in “my prime,” when an ache in his lower back sent him to the doctor. He thought it was a kidney stone. Instead, it was squamous cell carcinoma of his left kidney, a rare cancer his oncologist told him he had seen only a few times before. Chemotherapy didn’t work. He was told he was out of options. Then he got a second opinion, hundreds of miles away from his San Antonio-area town. Six years later, Eric sits down with our host, Pat Basu, MD, MBA, President & CEO of Cancer Treatment Centers of America® (CTCA), to share his cancer journey and to offer some advice to cancer patients: Don’t settle for anything less than the patient experience you deserve.
    33 min
  • S1E11 | TAPUR Study: The future of cancer care
    Like detectives working a cold case, scientists are using genes to unravel the mysteries of cancer’s origins and mutations, equipping doctors with new tools to target cancer at its source: the blunder coded in its molecular structure. Now, one groundbreaking clinical trial—the Targeted Agent and Profiling Utilization Registry (TAPUR™) Study—is revolutionizing our understanding of cancer at a cellular level. Led by the American Society of Clinical Oncology (ASCO), TAPUR is studying how commercially available anti-cancer drugs perform on a broader range of cancers, by matching the drugs to tumors with specific genomic mutations that the drugs are designed to target. Four years after the study’s launch, ASCO Chief Medical Officer Richard L., Schilsky, MD, FACP, FSCT, FASCO, sits down with our host, Pat Basu, MD, MBA, President & CEO of Cancer Treatment Centers of America® (CTCA), to share the strides TAPUR has made and how it’s impacted clinical trials on a global scale.
    44 min

About Focus On Cancer

From the publisher's feed

Tune in to Focus on Cancer, a podcast that answers everyday questions cancer patients have about the treatment and delivery of their care—answered by experts in the field of cancer care. Brought to…